Product Information
METOPROLOL TARTRATE 37.5 MG TB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0759 per EA under NDC 00378459301. Its NADAC has been published 137 times since Feb 21, 2024.
FDA first approved this application on Jan 16, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
37.5 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378459301
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METOPROLOL TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA076704FDA Approved
1/16/2004
TE Code
AB
On Market Since
3/29/2016
Pharmacological Classes
Price Statistics
The NADAC for METOPROLOL TARTRATE 37.5 MG TB has been published 137 times since Feb 21, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0759 per EA |
|---|---|
| All-time high | $0.0809 (Apr 10, 2024) |
| All-time low | $0.0581 (May 22, 2024) |
| 52-week high | $0.0773 |
| 52-week low | $0.0738 |
| Median price | $0.0759 |
| Average price | $0.0743 |
| Largest weekly change | -19.6% (May 22, 2024) |
| Weeks tracked | 137 |
| Tracking since | Feb 21, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the metoprolol tartrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
metoprolol tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOPROLOL TARTRATE 37.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL TARTRATE 37.5 MG TB, manufactured by Mylan Pharmaceuticals Inc., is $0.0759 per EA (NDC 00378459301), effective Sep 30, 2026.
How has the price of METOPROLOL TARTRATE 37.5 MG TB changed over time?
Over the history we have for it, the NADAC for METOPROLOL TARTRATE 37.5 MG TB has held within roughly two percent of its current level. It has been tracked across 137 weekly CMS publications since Feb 21, 2024.
What are the highest and lowest recorded NADAC prices for METOPROLOL TARTRATE 37.5 MG TB?
Since Feb 21, 2024, the NADAC for METOPROLOL TARTRATE 37.5 MG TB has ranged from a low of $0.0581 (May 22, 2024) to a high of $0.0809 (Apr 10, 2024), with a median of $0.0759 per EA.
Are there cheaper alternatives to METOPROLOL TARTRATE 37.5 MG TB?
No other NADAC-published product currently shares the active ingredient and strength of METOPROLOL TARTRATE 37.5 MG TB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures METOPROLOL TARTRATE 37.5 MG TB?
METOPROLOL TARTRATE 37.5 MG TB (NDC 00378459301) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.